This first study on the clinical impacts of stem cells on infantile diseases demonstrated that a high percentage of CD34+ cells in colostrum, as well as a high percentage of CD133+ cells and a low percentage of CD105+ cells in mature milk, was associated with a significantly increased risk of infantile eczema within their first 3 months after birth [1]. The gene discussed is CD34; the disease is Eczematoid dermatitis.